Wegovy Benefits Heart Disease Patients Regardless of Frailty

(MedPage Today) — Frailty did not appear to prevent adults with cardiovascular disease and overweight or obesity from reaping the benefits of semaglutide (Wegovy), a secondary analysis of SELECT trial data indicated.
By week 104, semaglutide…